<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04223466</url>
  </required_header>
  <id_info>
    <org_study_id>Subxiphoid ZYP1</org_study_id>
    <nct_id>NCT04223466</nct_id>
  </id_info>
  <brief_title>Video-assisted Thoracoscopic Thymectomy Versus Subxiphoid Procedure</brief_title>
  <official_title>Video-assisted Thoracoscopic Thymectomy Versus Subxiphoid Thymectomy: Short- Term and Long- Term Results</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Second Hospital of Shandong University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgerys used in thymectomy for myasthenia gravis and anterior mediastinal tumours have
      become much less invasive in recent years. In our study, the surgical technique which
      resected the thymus below the xiphoid process and the technique which was regarded as
      conventional video- assisted thoracoscopic surgery (VATS) thymectomy was compared.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 7, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2027</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale of postoperative pain</measure>
    <time_frame>within 3 days</time_frame>
    <description>in score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Operation time</measure>
    <time_frame>one day</time_frame>
    <description>in minutes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The amount of blood loss</measure>
    <time_frame>one day</time_frame>
    <description>in milliliter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of drainage</measure>
    <time_frame>with 7 days</time_frame>
    <description>in days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>with 7 days</time_frame>
    <description>in days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete remission rates</measure>
    <time_frame>5 years</time_frame>
    <description>Complete remission rates after 5 year follow-up of thymectomy for myasthenia gravis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rate</measure>
    <time_frame>5 years</time_frame>
    <description>Recurrence rate after 5 year follow-up of thymectomy for thymoma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>within 10 years</time_frame>
    <description>Overall survival in rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Thymectomy</condition>
  <arm_group>
    <arm_group_label>Subxiphoid group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subxiphoid procedure for thymectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VATS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Video-assisted thoracoscopic thymectomy through chest wall.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subxiphoid surgery procedure</intervention_name>
    <description>Subxiphoid procedure for thymectomy</description>
    <arm_group_label>Subxiphoid group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>VATS surgery procedure</intervention_name>
    <description>VATS procedure for thymectomy</description>
    <arm_group_label>VATS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Thymoma with or without myasthenia gravisï¼›

          2. Generalized myasthenia gravis not sensitive to conservative medicine treatment;

          3. Good cardiopulmonary function.

        Exclusion Criteria:

          1. Cardiopulmonary function can't bear surgery;

          2. Generalized myasthenia gravis with MuSK(+).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yunpeng Zhao</last_name>
    <phone>+8618766188692</phone>
    <email>zyp_baggio@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yunpeng</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250033</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunpeng</last_name>
      <phone>+8618766188692</phone>
      <email>zyp_baggio@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 8, 2020</study_first_submitted>
  <study_first_submitted_qc>January 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2020</study_first_posted>
  <last_update_submitted>January 8, 2020</last_update_submitted>
  <last_update_submitted_qc>January 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Video-assisted thoracoscopic surgery</keyword>
  <keyword>Subxiphoid approach</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

